See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Donald Trump
Artificial Intelligence
Social Media
Natural Disasters
Inflation
Infrastructure
Facebook
Swimming
Republican Party
Coronavirus
Property
European Union
Published • loading... • Updated

LEO Bulks up with Deal for Boehringer Skin Drug

Summary by Pharmaphorum
LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

6 Articles

PharmaphorumPharmaphorum
Center

LEO bulks up with deal for Boehringer skin drug

LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

Read Full Article
EuropaWire.euEuropaWire.eu

Boehringer Ingelheim and LEO Pharma Join Forces to Globalize SPEVIGO® Treatment for Generalized Pustular Psoriasis (GPP)

Open the article to view the coverage from EuropaWire.eu

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

LEO Pharma secures rights to Boehringer’s Spevigo for $105m - Pharmaceutical Technology

LEO has plans for Spevigo beyond generalised pustular psoriasis as it looks to boost its dermatological pipeline.

Read Full Article
dermatologytimes.comdermatologytimes.com

Boehringer Ingleheim, LEO Pharma Announce Partnership to Advance Spesolimab in GPP and Beyond

The pharmaceutical companies announced an exclusive global license and transfer agreement for the advancement and commercialization of Spevigo.

Read Full Article
endpoints.newsendpoints.news

Boehringer, LEO ink deal for IL-36 drug; Bayer’s Kerendia gets another indication

Plus, news about Illimis Therapeutics and Azurity: Boehringer Ingelheim, LEO Pharma sign €90M upfront pact: The deal focuses on Spevigo, an IL-36 drug approved to treat generalized pustular psoriasis. LEO will ...

Read Full Article
borsen.dkborsen.dk

Leo Pharma Buys Drug for Dkk 670 Million.

Leo Pharma buys drug for 670 million DKK. With the ambition to put even more fuel in the company's engine, Danish Leo Pharma has entered into a multi-million agreement with German pharmaceutical giant Boehringer

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

borsen.dk broke the news in on Monday, July 14, 2025.
Sources are mostly out of (0)

Similar News Topics

Pharma icon

Pharma

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal